News · 26 weeks59-62%
2026-02-012026-07-26
Mix2890d
- Insider14(50%)
- SEC Filings6(21%)
- Other5(18%)
- Earnings2(7%)
- Analyst1(4%)
Latest news
25 items- INSIDERChief Executive Officer Jayaraman Vivek K sold $52,665 worth of shares (16,666 units at $3.16) as part of a pre-agreed trading plan, decreasing direct ownership by 0.74% to 2,232,211 units (SEC Form 4)4 - CERUS CORP (0001020214) (Issuer)
- PRCerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026Cerus Corporation (NASDAQ:CERS) announced today that its second quarter 2026 financial results will be released on Thursday, July 30, 2026, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET, during which management will discuss the Company’s financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit the Investor Relations page of the Cerus website at http://ir.cerus.com. Participants may register for the call here. While not required, interested participants are encouraged to join 10 minutes prior to the start of the event. A replay will be avai
- SECCerus Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - CERUS CORP (0001020214) (Filer)
- INSIDERChief Financial Officer Green Kevin Dennis sold $99,105 worth of shares (33,676 units at $2.94) as part of a pre-agreed trading plan and gave a grant of 63,600 shares, decreasing direct ownership by 8% to 1,062,188 units (SEC Form 4) to cover withholding tax4 - CERUS CORP (0001020214) (Issuer)
- INSIDERChief Operating Officer Jayaraman Vivek K was granted 554,529 shares, gave a grant of 80,000 shares and sold $124,658 worth of shares (42,359 units at $2.94) as part of a pre-agreed trading plan, increasing direct ownership by 24% to 2,248,877 units (SEC Form 4) to satisfy withholding obligation4 - CERUS CORP (0001020214) (Issuer)
- INSIDERChief Legal Officer Jensen Chrystal gave a grant of 55,000 shares and sold $71,598 worth of shares (24,329 units at $2.94) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 966,657 units (SEC Form 4) (for withholding tax)4 - CERUS CORP (0001020214) (Issuer)
- INSIDERPresident and CEO Greenman William Mariner gave a grant of 192,500 shares and sold $299,937 worth of shares (101,919 units at $2.94) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 5,053,036 units (SEC Form 4) to cover taxes4 - CERUS CORP (0001020214) (Issuer)
- PRCerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT CongressCerus Corporation (NASDAQ:CERS) announced today a company-sponsored lunch symposium and a selection of abstracts at the International Society of Blood Transfusion (ISBT) 39th International ISBT Congress, taking place in Kuala Lumpur, Malaysia, from June 20 through June 24, 2026. Transfusion medicine experts and professionals from around the world are expected to attend the ISBT Congress. "We look forward to highlighting how blood centers around the world are leveraging INTERCEPT technology to strengthen blood safety, improve operational efficiency and enhance patient care," said Christian Boutemy, vice president, international commercial operations at Cerus. "This year's abstracts reflect
- INSIDERDirector Bjerkholt Eric sold $53,180 worth of shares (20,454 units at $2.60), decreasing direct ownership by 7% to 261,679 units (SEC Form 4)4 - CERUS CORP (0001020214) (Issuer)
- SECCerus Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation8-K - CERUS CORP (0001020214) (Filer)
- PRCerus Corporation Closes New Debt Facility of Up to $110 MillionRefinancing extends maturity and lowers cost of capital Enhances financial flexibility and positions Cerus to drive sustainable growth Anticipated annual cash interest expense savings of up to $3.5 million Cerus Corporation (NASDAQ:CERS) announced today the closing of a new debt facility with MidCap Financial (MidCap), providing up to $110 million. The facility consists of a 5-year term loan and an asset-backed revolving loan. The refinancing is expected to reduce annual cash interest expense by up to $3.5 million, reflecting lower borrowing costs and an approximately $30 million reduction in outstanding term loan balance. Initial proceeds from the loan, together with cash on hand,
- SECCerus Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders8-K - CERUS CORP (0001020214) (Filer)
- INSIDERDirector Lucena Ann was granted 60,000 shares, increasing direct ownership by 35% to 232,284 units (SEC Form 4)4 - CERUS CORP (0001020214) (Issuer)
- INSIDERDirector Bjerkholt Eric was granted 60,000 shares, increasing direct ownership by 27% to 282,133 units (SEC Form 4)4 - CERUS CORP (0001020214) (Issuer)
- INSIDERDirector Nachtsheim Jami K was granted 60,000 shares, increasing direct ownership by 29% to 268,362 units (SEC Form 4)4 - CERUS CORP (0001020214) (Issuer)
- INSIDERChief Operating Officer Jayaraman Vivek K sold $50,001 worth of shares (16,667 units at $3.00) as part of a pre-agreed trading plan, decreasing direct ownership by 1.00% to 1,656,707 units (SEC Form 4)4 - CERUS CORP (0001020214) (Issuer)
- INSIDERDirector Witney Frank was granted 60,000 shares, increasing direct ownership by 21% to 340,059 units (SEC Form 4)4 - CERUS CORP (0001020214) (Issuer)
- INSIDERDirector Gregory Dean A. was granted 60,000 shares, increasing direct ownership by 69% to 146,725 units (SEC Form 4)4 - CERUS CORP (0001020214) (Issuer)
- INSIDERDirector Shan Hua was granted 60,000 shares, increasing direct ownership by 45% to 192,386 units (SEC Form 4)4 - CERUS CORP (0001020214) (Issuer)
- SECSEC Form SD filed by Cerus CorporationSD - CERUS CORP (0001020214) (Filer)
- PRBradley L. Radoff Announces Intent to Withhold Votes from Chair and CEO William Greenman and Director Ann LucenaBradley L. Radoff, a significant shareholder of Cerus Corporation (NASDAQ:CERS) ("Cerus" or the "Company"), today announced his intention to withhold support for the Company's two director nominees at the upcoming 2026 annual meeting in the below open letter to shareholders. *** May 27, 2026 Fellow Shareholders, I am an individual shareholder in Cerus managing my own capital. In light of the Company's negative returns and failure to achieve profitability over the past decade, I will be withholding my votes from the reelection of William Greenman, the Chair of the Board of Directors (the "Board") and CEO of Cerus, and Ann Lucena, the Chair of the Board's Compensation Committee at the
- INSIDERChief Operating Officer Jayaraman Vivek K sold $50,001 worth of shares (16,667 units at $3.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.99% to 1,673,374 units (SEC Form 4)4 - CERUS CORP (0001020214) (Issuer)
- SECSEC Form 144 filed by Cerus Corporation144 - CERUS CORP (0001020214) (Subject)
- ANALYSTCerus upgraded by BTIG Research with a new price targetBTIG Research upgraded Cerus from Neutral to Buy and set a new price target of $4.00
- SECSEC Form 10-Q filed by Cerus Corporation10-Q - CERUS CORP (0001020214) (Filer)
CERS FAQ
7 questionsWhat does Cerus Corporation do?
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red...Where does CERS stock trade?
Cerus Corporation (CERS) is listed on NASDAQ.What sector and industry is CERS in?
Cerus Corporation operates in the Technology sector, EDP Services industry.When did Cerus Corporation go public?
Cerus Corporation (CERS) completed its IPO in 1997.What are analysts saying about CERS?
Cerus Corporation has had 4 recent analyst actions on file. The most recent action was from BTIG Research: Buy with a $400.00 price target on 2026-05-01. Recent price targets range from $375.00 to $500.00.What companies are similar to CERS?
Notable peers in the same industry include NEE (NextEra Energy Inc.), PDD (PDD Holdings Inc.), INFY (Infosys Limited), DASH (DoorDash Inc.), WDAY (Workday Inc.). Compare CERS side-by-side with any of them on Quantisnow.How can I track CERS on Quantisnow?
Quantisnow aggregates Cerus Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CERS to receive live email and push alerts on every new disclosure.